HMy2.CIR（人B 淋巴母細(xì)胞）  
產(chǎn)品品牌：ATCC
價(jià)格：詢價(jià)
上海研生生化試劑有限公司是一家專業(yè)經(jīng)營(yíng)ELISA 試劑盒、放免試劑盒、儀器耗材、科研細(xì)胞株的公司。 本產(chǎn)品HMy2.CIR（人B 淋巴母細(xì)胞）相關(guān)詳細(xì)信息請(qǐng)。
產(chǎn)品說(shuō)明：
Gong JH , et al. Characterization of a human cell line （NK-92） with phenotypical and functional characteristics of activated natural killer cells. Leukemia 8: 652-658, 1994. PubMed: 8152260 Tam YK , et al. Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapy. Hum. Gene Ther. 10: 1359-1373, 1999. PubMed: 10365666 Tam YK , et al. Immunotherapy of malignant melanoma in a SCID mouse model using the highly cytotoxic natural killer cell line NK-92. J. Hematother. 8: 281-290, 1999.
相關(guān)產(chǎn)品：
HMy2.CIR（人B 淋巴母細(xì)胞） 
OK（負(fù)鼠（opossum）腎細(xì)胞） 
FO（骨髓瘤細(xì)胞） 
RAW 264.7（單核巨噬細(xì)胞白血病） 
P19（畸胎癌細(xì)胞） 
C6（膠質(zhì)瘤細(xì)胞） 
RBL-2H3（白血病細(xì)胞） 
SiHa（子宮頸癌細(xì)胞）